Jan Vodička

Jan Vodička

Auto-generated profile, based on publicly available information

Jan Vodička

Porodnicko gynekologicka klinika LF UP FN Olomouc, Olomouc, Czech Republic

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2022 in Česká gynekologie
Verified
Journal Article
Closed access
KCKarel Crha
Karel Crha
Michal JešetaMichal Ješeta
Michal Ješeta
RPRadovan Pilka
Radovan Pilka
MKMarek Kašík
Marek Kašík
LMLenka Mekiňová
Lenka Mekiňová
TCTomas Crha
Tomas Crha
Objective: The goal of this article is to present the current knowledge of Klinefelter syndrome and its impact on male reproductive function as well as the current treatment options. Methods: PubMed/Medline, WoS and Scopus were searched for articles indexed until November 2021. Text: Klinefelter syndrome is a chromosomal aberration with an additional X chromosome in males. This may adversely affect testicular growth and spermatogenesis, thus resulting in male infertility. Recently, new knowledge has appeared about the treatment of male infertility. Conclusion: Interdisciplinary approach enables early diagnosis and treatment of patients with Klinefelter syndrome. Assisted reproductive technology is essential for infertility treatment in patients with Klinefelter syndrome.

23 February 2023 in Česká gynekologie
Verified
Journal Article
Closed access
JVJan Vodička
Jan Vodička
JDJiří Dostál
Jiří Dostál
DHDušan Holub
Dušan Holub
RPRadovan Pilka
Radovan Pilka
PDPetr Džubák
Petr Džubák
TOTomáš Oždian
Tomáš Oždian
Cervical mucus is a viscous fluid functioning as a cervix plug. Products of the endometrial and cervical glands can be detected in the cervical mucus. Cervical mucus is further enriched with transudate originating from the fallopian tubes and proteins originating from the ovaries, peritoneum and distant tissues. With increasing levels of ovarian estrogens, the properties of cervical mucus for possible collection and processing change appropriately. For these reasons, we chose a group of 10 patients treated in the center of assisted reproduction by controlled ovarian stimulation for in vitro fertilization. This study focuses on the proteomic characterization of cervical mucus and localizes the possible sources of the identified proteins. The most abundant proteins were extracellular proteins, mainly mucins; however, most of the identified proteins, present usually in lower quantities, were of intracellular origin. The tissue analysis revealed that proteins from female reproductive organs are also expressed in other tissues in addition to female reproductive organs, but also proteins specific to the testis, liver, placenta, retina, and cerebellum. This study confirms the suitability and high potential of cervical mucus as a source of proteomic bio markers not only for the of the female tract.

23 December 2022 in Česká gynekologie
Verified
Journal Article
Closed access
LMLenka Mekiňová
Lenka Mekiňová
Michal JešetaMichal Ješeta
Michal Ješeta
ICIgor Crha
Igor Crha
KCKarel Crha
Karel Crha
JVJan Vodička
Jan Vodička
RPRadovan Pilka
Radovan Pilka
Objective: A summary of new knowledge on embryo implantation in dependence on quality of the endometrium. Methods: Literature review from August 2022 of the relevant publications in Web of Science, Scopus and PubMed/ Medline databases, focused on "endometrial receptivity", "polycystic ovary syndrome", "endometriosis", "SARS-CoV-2". Results:The receptive state of the endometrium is a result of physiological remodeling and immune system activity modulated by the microbio me. This balance can be disturbed by myomas, polyps, sactosalpings, adenomyosis, endometriosis, polycystic ovary syndrome, infections. The effect of SARS-CoV-2 infection is being discussed. For a successful implantation, timing of transfer is crucial. The ultrasound examination is used conventionally. In specific cases, hysteroscopy and endometrium bio psy are recommended. Histological and immunohistochemical evaluation is performed together with examination of microbio me or transcriptome. To support the implantation, gestagenes are used, or metformin in the patients with polycystic ovary syndrome. In cases of a repeated implantation failure, the intrauterine infusion of mononuclear cells or platelet rich plasma is used, subcutaneous application of granulocyte colony stimulating growth factor, intravenous application of atosiban or intrauterine application of human chorionic gonadotropin. Conclusion: Recent research in the field of transcriptomics, proteomics and reproductive immunology uncovers the process of implantation more deeply and opens a new stage of the assisted reproduction.